Comac Medical Group

Business news, market intelligence, and global industry analysis.

The Latest

Could subcutaneous PD-1 therapy reshape oncology treatment logistics in China?

Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Comac Medical Group acquires ILIFE Consulting to expand oncology and biotech CRO services in Europe

Comac Medical acquires French CRO ILIFE Consulting to expand European clinical trial services in oncology and rare diseases—find out what this means for biotech sponsors.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

May 25, 2025